Panacea Biotec Financials
NSE: PANACEABIO | BSE: 531349
₹389.05
As on 03-Sep-2026 15:57IST
Market cap
₹2,385 Cr
Revenue (TTM)
₹673 Cr
P/E Ratio
--
P/B Ratio
2.8
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
672.64
|
559.09
|
559.17
|
459.95
|
661.23
|
624.81
|
|||||
|
Total Income
|
688.11
|
579.75
|
584.96
|
511.61
|
672.20
|
634.78
|
|||||
|
Total Expenditure
|
670.45
|
585.01
|
579.23
|
557.91
|
674.44
|
548.18
|
|||||
|
EBITDA
|
2.19
|
-25.91
|
-20.06
|
-97.96
|
-13.20
|
76.63
|
|||||
|
Depreciation
|
32.57
|
34.81
|
36.71
|
39.12
|
43.78
|
45.59
|
|||||
|
EBIT
|
-30.38
|
-60.73
|
-56.77
|
-137.08
|
-56.98
|
31.04
|
|||||
|
Interest
|
6.37
|
3.88
|
3.58
|
4.44
|
180.84
|
185.34
|
|||||
|
Other Income
|
15.47
|
20.66
|
25.80
|
51.66
|
10.97
|
9.98
|
|||||
|
Exceptional Items
|
10.92
|
35.99
|
36.03
|
102.66
|
1,676.21
|
--
|
|||||
|
Profit before Tax
|
-10.36
|
-7.95
|
1.48
|
12.81
|
1,449.36
|
-144.25
|
|||||
|
Provision for Tax
|
-1.44
|
0.77
|
2.98
|
46.55
|
371.02
|
1.96
|
|||||
|
Profit after Tax
|
-8.92
|
-8.72
|
-1.51
|
-33.75
|
1,078.33
|
-146.20
|
|||||
|
Minority Interest
|
1.80
|
0.35
|
0.33
|
0.51
|
-0.02
|
-0.04
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
-7.12
|
-8.37
|
-1.17
|
-33.24
|
1,078.32
|
-147.70
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
834.84
|
834.79
|
842.05
|
843.60
|
876.64
|
-228.69
|
|||||
|
Minority Interest
|
1.80
|
-4.17
|
-3.82
|
-3.49
|
-2.98
|
-3.00
|
|||||
|
Non-Current Liabilities
|
84.61
|
103.62
|
265.09
|
270.70
|
85.10
|
959.99
|
|||||
|
Current Liabilities
|
348.68
|
366.99
|
308.98
|
329.73
|
773.77
|
447.24
|
|||||
|
Total Liabilities
|
1,262.17
|
1,301.23
|
1,412.30
|
1,442.64
|
1,758.87
|
1,177.53
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
719.70
|
756.05
|
926.83
|
874.32
|
744.57
|
666.41
|
|||||
|
Current Assets
|
513.04
|
545.18
|
485.47
|
562.32
|
950.56
|
474.23
|
|||||
|
Total Assets
|
1,262.17
|
1,301.23
|
1,412.30
|
1,442.64
|
1,758.87
|
1,177.53
|
|||||
|
Total Debt*
|
--
|
22.21
|
20.99
|
20.22
|
34.16
|
819.53
|
|||||
|
Net Current Assets
|
164.36
|
178.19
|
176.49
|
232.59
|
176.79
|
26.99
|
|||||
|
Contingent Liabilities
|
--
|
367.09
|
369.39
|
655.75
|
368.17
|
406.99
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-27.37
|
3.47
|
-422.45
|
-108.45
|
106.76
|
|||||
|
Cash Flow from Investing Activities
|
--
|
64.98
|
6.66
|
430.33
|
1,282.57
|
-47.68
|
|||||
|
Cash from Financing Activities
|
--
|
-2.66
|
-2.81
|
-18.37
|
-1,175.84
|
-47.11
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
34.95
|
7.32
|
-10.49
|
-1.72
|
11.98
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-1.86
|
-1.37
|
-0.19
|
-5.43
|
176.05
|
-24.11
|
|||||
|
Cash EPS (₹)
|
-1.16
|
4.26
|
5.75
|
0.88
|
183.20
|
-16.43
|
|||||
|
Adjusted Book Value (₹)
|
136.66
|
136.29
|
137.48
|
137.73
|
143.12
|
-37.34
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
-4.47
|
0.57
|
-68.97
|
-17.71
|
17.43
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-5.35
|
-6.11
|
-60.81
|
230.28
|
-16.32
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-0.47
|
0.59
|
1.94
|
217.12
|
5.36
|
|||||
|
ROE (%)
|
-1.37
|
-1.04
|
-0.18
|
-3.92
|
332.85
|
--
|
|||||
|
ROA (%)
|
-0.70
|
-0.64
|
-0.11
|
-2.12
|
74.05
|
-10.69
|
|||||
|
EBIT Margin (%)
|
-4.52
|
-10.86
|
-10.15
|
-29.80
|
-8.62
|
4.97
|
|||||
|
Net Margin (%)
|
-1.30
|
-1.50
|
-0.26
|
-6.60
|
160.42
|
-23.03
|
|||||
|
Cash Profit Margin (%)
|
--
|
4.64
|
6.19
|
1.14
|
161.39
|
-15.36
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
10.26
|
-0.01
|
21.57
|
-30.44
|
5.83
|
14.84
|
|||||
|
EBIT Growth (%)
|
36.14
|
-6.96
|
58.59
|
-140.58
|
-283.60
|
266.43
|
|||||
|
Net Profit Growth (%)
|
99.13
|
-479.34
|
95.54
|
-103.13
|
837.56
|
24.88
|
|||||
|
EPS Growth (%)
|
-162.02
|
-613.58
|
96.47
|
-103.08
|
830.09
|
23.97
|
|||||
|
Book Value Growth (%)
|
--
|
-0.86
|
-0.18
|
-3.77
|
483.32
|
-237.12
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
-208.88
|
--
|
--
|
--
|
0.84
|
--
|
|||||
|
Price / Book Value
|
2.85
|
3.23
|
0.88
|
0.79
|
1.04
|
-4.75
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
132.73
|
-497.76
|
111.94
|
-9.89
|
-160.66
|
20.44
|
|||||
|
Close Price (₹)
|
565.85
|
441.25
|
121.55
|
108.45
|
148.20
|
178.90
|
|||||
|
High Price (₹)
|
647.50
|
490.55
|
202.50
|
191.70
|
453.70
|
265.00
|
|||||
|
Low Price (₹)
|
292.40
|
112.35
|
107.00
|
107.00
|
147.95
|
81.73
|
|||||
|
Market Cap (₹ Cr)
|
2,384.80
|
2,698.97
|
742.97
|
663.66
|
908.03
|
1,086.58
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.03
|
0.03
|
0.02
|
0.02
|
0.04
|
-3.58
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
1.47
|
1.49
|
1.57
|
1.71
|
1.23
|
1.06
|
|||||
|
Quick Ratio
|
0.92
|
0.90
|
1.00
|
1.09
|
0.95
|
0.67
|
|||||
|
Interest Coverage
|
-0.63
|
-1.05
|
1.41
|
3.89
|
9.01
|
0.22
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
10.93
|
12.98
|
10.27
|
13.07
|
12.35
|
13.55
|
|||||
|
Asset Turnover
|
0.53
|
0.41
|
0.40
|
0.30
|
0.48
|
0.48
|
|||||
|
Receivable days
|
--
|
42.20
|
37.70
|
54.62
|
43.66
|
42.68
|
|||||
|
Inventory Days
|
--
|
127.15
|
121.93
|
159.84
|
101.55
|
89.66
|
|||||
|
Payable days
|
--
|
339.61
|
256.06
|
297.63
|
335.05
|
397.33
|
|||||
|
Cash Conversion Cycle
|
--
|
-170.26
|
-96.42
|
-83.17
|
-189.84
|
-264.98
|